ARDEE, Ireland -
Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company’s global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott’s existing presence in women’s health care and adds new therapeutic and geographic markets. At closing approximately 1,900 employees of P&G’s pharmaceuticals business joined Warner Chilcott and the Company added manufacturing facilities in Germany and Puerto Rico.
“This is a transformational acquisition that extends our presence to include many of the major pharmaceutical markets around the World and significantly enhances the scale and diversity of our business,” said Roger Boissonneault, President and Chief Executive Officer of Warner Chilcott. “Importantly, the increased scale afforded by this deal provides us with the ability to pursue a broader range of R&D projects to fuel our long-term growth.”
To finance the acquisition, the Company used a combination of cash on hand and borrowings under new senior secured credit facilities. The new senior secured credit facilities provided for US$3.2 billion in financing and are comprised of a US$250 million revolving credit facility with a five-year maturity, a US$1.0 billion Term Loan A with a five year maturity, a US$1.6 billion Term Loan B with a five-and-a-half year maturity and a US$350 million delayed-draw Term Loan B with a five-and-a-half year maturity. Borrowings under the Term Loan A and revolving credit facility bear interest at LIBOR plus 3.25% and under the Term Loan B and delayed-draw facility at LIBOR plus 3.50%, in all cases subject to a 2.25% floor on LIBOR. At the closing, the Company borrowed a total of US$2.6 billion under the term loan facilities and did not borrow under the revolving credit facility or the delayed-draw term loan facility. The Company’s existing US$380 million aggregate principal amount of 8 3/4% senior subordinated notes remain outstanding.
The Company
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women’s healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
Source: Warner Chilcott plc
Rochelle Fuhrmann, Investor Relations of Warner Chilcott, +1-973-442-3281, rfuhrmann at wcrx.com
Related Press Releases
Cell Biosciences Completes Acquisition of Alpha InnotechOctober 27th, 2009 SANTA CLARA, California -
Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp.
Abbott to Acquire Solvay Pharmaceuticals BusinessSeptember 27th, 2009 ABBOTT PARK, Illinois -
- Diversifies Abbott's pharmaceutical products, expanding international growth platform
- Supports long-term strategy to bolster presence in key global emerging markets
- Adds substantial R&D spending capacity to accelerate promising pipeline programs
- Establishes Abbott's presence in the growing global vaccines market
- Provides accretion of approximately US$0.10 to ongoing EPS in 2010, accelerating to more than US$0.20 by 2012, increasing thereafter
Abbott today announced a definitive agreement with the Solvay Group for Abbott to acquire Solvay's pharmaceuticals business for EUR 4.5 billion (US$6.6 billion) in cash, providing Abbott with a large and complementary portfolio of pharmaceutical products and a significant presence in key global emerging markets. The acquisition also includes full global rights to the fenofibrate franchise.
The Digital Movie Service Headweb Signs Distribution Licensing Agreement With Warner Bros.September 8th, 2009 STOCKHOLM - Headweb today kicks off a collaboration with film company Warner Bros., who's movie library will now be available to users through the online, award-winning movie service Headweb. - We are incredibly excited to work with Warner Bros., as this is confirmation that Headweb is about to become the leading movie service on the Internet.
Dean Foods Completes Acquisition of AlproJuly 5th, 2009 DALLAS -
Dean Foods Company (NYSE: DF) today announced that it has completed the previously disclosed acquisition of the Alpro division of Vandemoortele N.V. for a transaction price of approximately euro 325 million.
Box Office Awakens to "The Hangover"June 14th, 2009 LONDON - Director Todd Phillips' New Hit Comedy Opens #1 at the UK Box Office and Holds #1 for the 2nd Week at the U.S. Box Office
Warner Bros.
ADM Completes Acquisition of German Chocolate ManufacturerMay 28th, 2009 ROLLE, Switzerland - Archer Daniels Midland Company (NYSE: ADM) announced today that is has completed the acquisition of the Schokinag-Schokolade-Industrie Herrmann GmbH & Co. KG, following approval by relevant antitrust authorities.
Warner Bros. Pictures UK Teams up With Vertigo on Nick Love's the FirmMay 14th, 2009 LONDON - Warner Bros. Pictures UK today announces that it will be releasing Nick Love's latest movie THE FIRM in a joint venture with Vertigo Films.
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.April 14th, 2009 BROOMFIELD, Colorado - New Business Spin-off to Focus on Drug Development for Neurological Conditions
Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, announced today the formation of Neuera Pharmaceuticals, Inc., a drug development company. The new company will focus on the discovery and development of proprietary small molecule drugs for acute and chronic neurological conditions where the mechanism of defective energy metabolism or hypometabolism is involved.
Inmarsat Completes Acquisition of Stratos Global and Implements New Distribution Terms With PartnersApril 14th, 2009 LONDON - Inmarsat plc (LSE: ISAT), the leading provider of global mobile satellite communications services, today confirms that it has completed the acquisition of Stratos Global Corporation ('Stratos'). Inmarsat has also signed new distribution agreements with all of its major partners.
HIKMA - 2008 Preliminary Results Interview With CEOMarch 16th, 2009 LONDON - Hikma Pharmaceuticals today announced strong revenue growth and stable
net profits despite a loss at the company's US Generics business. The
weakness in the US was offset by a strong performance from the multinational
Pharma company's Injectable and Branded businesses.
Related News
Drugmaker Warner Chilcott says it finished moving headquarters to Ireland from BermudaAugust 21st, 2009 Warner Chilcott completes move to IrelandNEW YORK — Drug developer Warner Chilcott said Friday it completed its move to Ireland from Bermuda. The company is now Warner Chilcott PLC rather than Warner Chilcott Ltd.
Report: P&G discussions on selling pharmaceutical business advancingJuly 22nd, 2009 P&G drug-business sale talks advance, reports sayCINCINNATI — Talks on a sale of Procter & Gamble Co.'s pharmaceutical business are reportedly advancing. The Wall Street Journal in Wednesday's editions cited unidentified people familiar with the matter who say several potential buyers include specialty drug maker Warner Chilcott Ltd., and private-equity firm Cerberus Capital Management LP, and that a possible sale price is some $3 billion.
WSJ: Warner Chilcott could announce $3 billion purchase of P&G's prescription drug unit MondayAugust 23rd, 2009 Report: Warner Chilcott to buy P&G's pharma unitDrug maker Warner Chilcott PLC could announce a $3 billion takeover of Procter & Gamble Co.'s prescription drug business as early as Monday, The Wall Street Journal has reported, citing unidentified people familiar with the deal. Asked to comment on the report Sunday, P&G spokesman Tom Millikin told The Associated Press that the consumer products company does not respond to rumor or speculation.
Procter & Gamble's pharma sale follows strategyAugust 24th, 2009 P&G sale fits strategyCincinnati-based Procter & Gamble Co. has been selling slower-growth brands to focus more on consumer businesses it thinks has higher potential.
TD Ameritrade completes $606 million acquisition of thinkorswim GroupJune 12th, 2009 TD Ameritrade completes thinkorswim acquisitionOMAHA, Neb. — Online brokerage TD Ameritrade Holding Corp.
King Pharmaceuticals says 2nd quarter profit falls, but performance tops expectationsAugust 6th, 2009 King Pharmaceuticals reports 2Q profit dropBRISTOL, Tenn. — Drug developer King Pharmaceuticals said Thursday its second-quarter profit dropped, as generic competition continued to hurt drug sales.
Moog completes $90 million purchase of GE Aviation product lineSeptember 30th, 2009 Moog completes purchase of GE Aviation productEAST AURORA, N.Y. — Aircraft systems maker Moog Inc.
Republic Airways parent completes acquisition of Midwest Airlines for $31M in cash and debtJuly 31st, 2009 Republic Airways parent closes purchase of MidwestMILWAUKEE — Republic Airways Holdings says it has completed its acquisition of privately held Midwest Airlines for $31 million in cash and debt. Indianapolis-based Republic Airways Holdings is a regional carrier that currently flies under contract for other airlines.
Time Warner to split off AOLineMay 28th, 2009 WASHINGTON - Time Warner Thursday announced plans to spin off AOL as an independent company calling the end to the January 2001 massive media marriage as "best outcome" for both companies. "We believe that a separation will be the best outcome for both Time Warner and AOL," said Time Warner chief executive Jeff Bewkes, in a prepared statement.
GHL Acquisition announces CEO leaving to comply with Nasdaq listing requirementsSeptember 21st, 2009 GHL Acquisition announces CEO leavingNEW YORK — GHL Acquisition Corp. said Monday that its chief executive resigned so the company could comply with requirements for having its shares listed on the Nasdaq Stock Market.
